Qing Sang

Title: Qing Sang - Innovator in Minimally Invasive Glaucoma Surgery

Introduction

Qing Sang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of ophthalmology, particularly in the treatment of open-angle glaucoma. His innovative approach focuses on minimally invasive surgical techniques that enhance patient outcomes.

Latest Patents

Qing Sang holds a patent for a groundbreaking procedure titled "Minimally invasive ab interno triple surgery for open-angle glaucoma." This patent describes a method that involves knotting and fixing a suture at the head end of an optical fiber catheter. The procedure includes performing miosis with carbachol, injecting viscoelastic into the anterior chamber, and making a lateral incision at the infratemporal corneal limbus to place the optical fiber catheter. The surgery further involves cutting the Schlemm's canal, inserting an optical fiber, and carefully managing the viscoelastic to ensure optimal results. This innovative technique aims to improve the surgical experience for patients suffering from glaucoma.

Career Highlights

Qing Sang is affiliated with the Beijing Institute of Ophthalmology at Beijing Tongren Hospital, which is part of Capital Medical University. His work in this esteemed institution has allowed him to develop and refine his surgical techniques, contributing to advancements in ophthalmic surgery.

Collaborations

Qing Sang has collaborated with notable colleagues in his field, including Ningli Wang and Jin Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge in ophthalmology.

Conclusion

Qing Sang's contributions to minimally invasive glaucoma surgery exemplify the impact of innovation in medical science. His patent and career achievements reflect a commitment to improving patient care through advanced surgical techniques.